|
GB0012528D0
(en)
*
|
2000-05-23 |
2000-07-12 |
Univ Palackeho |
Triterpenoid derivatives
|
|
GB0219052D0
(en)
*
|
2002-08-15 |
2002-09-25 |
Cyclacel Ltd |
New puring derivatives
|
|
GB0226583D0
(en)
*
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
GB0229581D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Cyclacel Ltd |
Use
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
JP2007514759A
(ja)
|
2003-12-19 |
2007-06-07 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
US7550598B2
(en)
|
2004-08-18 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
RU2007116861A
(ru)
|
2004-10-07 |
2009-03-20 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
P13-киназы
|
|
JP2008516973A
(ja)
|
2004-10-15 |
2008-05-22 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス，インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
|
DE102005048072A1
(de)
*
|
2005-09-24 |
2007-04-05 |
Bayer Cropscience Ag |
Thiazole als Fungizide
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
AU2006308889A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
GABA receptor mediated modulation of neurogenesis
|
|
DE102006001161A1
(de)
*
|
2006-01-06 |
2007-07-12 |
Qiagen Gmbh |
Verfahren zum Nachweis von Cytosin-Methylierungen
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US7691868B2
(en)
|
2006-04-06 |
2010-04-06 |
Boehringer Ingelheim International Gmbh |
Thiazolyl-dihydro-quinazoline
|
|
US7517995B2
(en)
*
|
2006-04-06 |
2009-04-14 |
Boehringer Ingelheim International Gmbh |
Thiazolyl-dihydro-cyclopentapyrazole
|
|
US20070238746A1
(en)
*
|
2006-04-06 |
2007-10-11 |
Trixi Brandl |
Thiazolyl-dihydro-chinazoline
|
|
EP2010542B1
(en)
*
|
2006-04-12 |
2012-01-25 |
Vertex Pharmaceuticals Incorporated |
4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridines as plk1 protein kinase inhibitors for the treatment of proliferative disorders
|
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
US8779154B2
(en)
|
2006-09-26 |
2014-07-15 |
Qinglin Che |
Fused ring compounds for inflammation and immune-related uses
|
|
EA200970361A1
(ru)
|
2006-10-09 |
2010-02-26 |
Такеда Фармасьютикал Компани Лимитед |
Ингибиторы киназы
|
|
JP5681855B2
(ja)
|
2007-10-12 |
2015-03-11 |
アストラゼネカ エービー |
プロテインキナーゼの阻害剤
|
|
EP2100894A1
(en)
|
2008-03-12 |
2009-09-16 |
4Sc Ag |
Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
|
|
JP5530422B2
(ja)
*
|
2008-04-07 |
2014-06-25 |
アムジエン・インコーポレーテツド |
細胞周期阻害薬としてのｇｅｍ−二置換およびスピロ環式アミノピリジン／ピリミジン
|
|
WO2010043676A1
(en)
*
|
2008-10-17 |
2010-04-22 |
Boehringer Ingelheim International Gmbh |
Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
UY32748A
(es)
|
2009-07-02 |
2011-01-31 |
Novartis Ag |
2-carboxamida-cicloamino-ureas
|
|
WO2011110612A1
(en)
|
2010-03-10 |
2011-09-15 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
WO2013059634A1
(en)
|
2011-10-20 |
2013-04-25 |
The Regents Of The University Of California |
Use of cdk9 inhibitors to reduce cartilage degradation
|
|
US10300073B2
(en)
|
2014-10-14 |
2019-05-28 |
The Regents Of The University Of California |
Use of CDK9 and BRD4 inhibitors to inhibit inflammation
|
|
US20170283445A1
(en)
|
2016-04-05 |
2017-10-05 |
University Of South Carolina |
Small Molecule Inhibitors Selective For Polo-Like Kinase Proteins
|
|
US12428423B2
(en)
|
2017-04-01 |
2025-09-30 |
Shengke Pharmaceuticals (Jiangsu) Ltd. |
1H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitor
|
|
JP7233743B2
(ja)
|
2017-08-11 |
2023-03-07 |
晟科薬業（江蘇）有限公司 |
プロテインキナーゼ阻害剤としての１ｈ－ピラゾロ［４，３－ｈ］キナゾリン系化合物
|
|
US11162083B2
(en)
|
2018-06-14 |
2021-11-02 |
University Of South Carolina |
Peptide based inhibitors of Raf kinase protein dimerization and kinase activity
|
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
|
US11384083B2
(en)
|
2019-02-15 |
2022-07-12 |
Incyte Corporation |
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
|
|
WO2020180959A1
(en)
|
2019-03-05 |
2020-09-10 |
Incyte Corporation |
Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
|
|
WO2020205560A1
(en)
|
2019-03-29 |
2020-10-08 |
Incyte Corporation |
Sulfonylamide compounds as cdk2 inhibitors
|
|
WO2020223558A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
Tricyclic amine compounds as cdk2 inhibitors
|
|
WO2020223469A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
|
|
ES2972864T3
(es)
*
|
2019-08-02 |
2024-06-17 |
Chengdu Cynogen Bio Pharmaceutical Tech Co Ltd |
Compuestos de 1H-[1,2,3]triazolo[4,5-h]quinazolina que actúan como inhibidores de una proteína cinasa
|
|
AU2020328025A1
(en)
|
2019-08-14 |
2022-03-03 |
Incyte Corporation |
Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
|
|
JOP20220087A1
(ar)
|
2019-10-11 |
2023-01-30 |
Incyte Corp |
أمينات ثنائية الحلقة كمثبطات لـ cdk2
|
|
KR20230057380A
(ko)
*
|
2020-08-27 |
2023-04-28 |
셍커 파마슈티컬스 (지앙수) 엘티디. |
신규한 선택적 flt3 억제제로서의 1h-이미다조[4,5-h]퀴나졸린 화합물
|
|
CN116601155A
(zh)
*
|
2020-11-26 |
2023-08-15 |
成都赛璟生物医药科技有限公司 |
杂芳基并喹唑啉类化合物作为蛋白激酶抑制剂
|
|
EP4284371A4
(en)
*
|
2021-01-29 |
2024-12-18 |
Virokyne Therapeutics, Llc |
SELECTIVE CYCLIN-DEPENDENT KINASE INHIBITORS AND METHODS FOR THE THERAPEUTIC USE THEREOF
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
WO2024245406A1
(zh)
*
|
2023-06-01 |
2024-12-05 |
成都赛璟生物医药科技有限公司 |
1h-[1,2,3]三唑并[4,5-h]喹唑啉类化合物作为蛋白激酶抑制剂
|